SecBot SecBot
8-K ·Filed Jul 2, 2026

QCLS

Q/C TECHNOLOGIES, INC.
NEUTRAL
Impact 4/10
Horizonmonths Processed3mo ago SEC0001493152-26-031946
8-K material event: Items 1.02
Actionable Insight • Neutral

The pivot from crypto mining to optical AI computing is a strategic shift with no near-term revenue visibility. Monitor for progress on OPU development, potential capital raises, and any partnership announcements. The involvement of controversial advisors may attract retail attention but adds execution risk.

DirectionNeutral
Confidencemedium
Horizonmonths
Final — all horizons settled through T+60d
QCLS ▼ -78.37% at T+60d
NEUTRAL call -78.37% · α vs SPY -81.93% · entry $3.85 → $0.8329
Entry = T+0 close
Jul 2, 2026
via day close
T+1d
0.00%
call 0.00% · α -0.87%
$3.85
settled 4mo ago
T+5d
-3.38%
call -3.38% · α -4.31%
$3.72
settled 4mo ago
T+20d
-29.61%
call -29.61% · α -29.20%
$2.71
settled 3mo ago
T+60d
-78.37%
call -78.37% · α -81.93%
$0.8329
settled 29d ago

Price Chart

Loading chart...

Executive Summary

Q/C Technologies terminated its crypto-mining license agreement with LightSolver and is pivoting entirely to an optical processing unit (OPU) initiative for AI inference. The company is relocating to San Francisco, building a photonics lab, and hiring engineers from photonics/AI firms. No financial terms or revenue impact were disclosed.

Key Facts

  • Terminated Technology License and Development Agreement with LightSolver for crypto-mining hardware, effective June 26, 2026
  • LPU Holdings relieved from all future milestone payments; LightSolver forfeits contingent consideration
  • Company fully focusing on optical processing unit (OPU) for AI inference, announced March 18, 2026
  • Relocating headquarters to San Francisco and establishing a 4,800-square-foot integrated photonics lab
  • Hired engineers from IPG Photonics, Neurophos, and IonQ; advisors include Martin Shkreli and James Altucher

Financial Impact

No financial figures disclosed; termination relieves LPU from milestone payments but no cash impact stated

Risk Factors

  • History of multiple name changes and business pivots (Akers Biosciences, MyMD, TNF Pharmaceuticals) raises credibility concerns
  • Optical computing for AI is highly competitive and capital-intensive; no revenue or timeline provided
  • Potential need for dilutive financing given $31M market cap and no disclosed revenue from either initiative

Market Snapshot

Exchange
Nasdaq
Sector
In Vitro & In Vivo Diagnostic Substances

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-031946
Document: 0001493152-26-031946-index-headers.html0001493152-26-031946
Document: 0001493152-26-031946-index.html0001493152-26-031946
Document: 0001493152-26-031946.txt0001493152-26-031946
5 reports for QCLS
Performance horizon
Filters
Rows
Reports for QCLS — sortable, filterable
TypeNow
Oct 1, 2026
25d ago
Press Release
NEUTRAL ★ 3/10
$0.7753awaiting T+20—$0.4500 (−41.96%)
Sep 30, 2026
26d ago
Press Release
NEUTRAL ★ 3/10
$0.8511awaiting T+20—$0.4500 (−47.13%)
Sep 18, 2026
5w ago
8-K
NEUTRAL ★ 3/10
$0.7847 $0.5000▼ −36.28%▼ −35.37%$0.4500 (−42.65%)
Jul 2, 2026
16w ago
8-K
NEUTRAL ★ 4/10
$3.85 $2.71▼ −29.61%▼ −29.20%$0.4500 (−88.31%)
Apr 29, 2026
25w ago
10-K/A
NEUTRAL ★ 2/10
$3.75 $4.37▲ +16.53%▲ +11.31%$0.4500 (−88.00%)
Showing 5 of 5

US Market Status

Market Closed — Opens in 2h 35m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 2, 2026